| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Saluda Medical Expands Access to First and Only FDA-Approved Closed-Loop Surgical Paddle Lead with Full US Commercial Release of CAP24 | 238 | PR Newswire | BLOOMINGTON, Minn., Oct. 6, 2026 /PRNewswire/ -- Saluda Medical, Inc. (ASX: SLD, "Saluda" or the "Company") a commercial-stage medical device company focused on... ► Artikel lesen | |
| SALUDA MEDICAL Aktie jetzt für 0€ handeln | |||||
| Mo | SALUDA MEDICAL, INC.: Expands Access with Full US Commercial Release of CAP24 | - | ASX | ||
| 24.09. | SALUDA MEDICAL, INC.: Initial Director's Interest Notice | - | ASX | ||
| 24.09. | SALUDA MEDICAL, INC.: Director Appointment/Resignation | 1 | ASX | ||
| 14.09. | SALUDA MEDICAL, INC.: Final Director's Interest Notice - B Regan | 1 | ASX | ||
| 10.09. | SALUDA MEDICAL, INC.: FY26 Consolidated Financial Statements | - | ASX | ||
| 10.09. | Buy, hold, sell: Generation Development, Fletcher Building, Saluda Medical shares | 2 | The Motley Fool Australia | ||
| 07.09. | SALUDA MEDICAL, INC.: CEO Transition | 1 | ASX | ||
| 28.08. | SALUDA MEDICAL, INC.: Change in substantial holding | - | ASX | ||
| 28.08. | Saluda Medical FY26 slides: revenue jumps 28%, stock falls on execution risk | 1 | Investing.com | ||
| 28.08. | SALUDA MEDICAL, INC.: FY26 Results Presentation | - | ASX | ||
| 28.08. | SALUDA MEDICAL, INC.: FY26 Full Year Results | - | ASX | ||
| 28.08. | SALUDA MEDICAL, INC.: Preliminary Final Report | - | ASX | ||
| 18.08. | SALUDA MEDICAL, INC.: FY26 Results & Webinar, 2026 AGM Notification | - | ASX | ||
| 04.08. | Saluda Medical (ASX:SLD) beats FY26 as CAP24 door opens | - | Stocks Down Under | ||
| 30.07. | Buy, hold, sell: Saluda Medical, Tasmea, Treasury Wine Estates shares | 1 | The Motley Fool Australia | ||
| 30.07. | Saluda Medical FY26 slides: revenue tops guidance as growth accelerates | 1 | Investing.com | ||
| 28.07. | SALUDA MEDICAL, INC.: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 28.07. | SALUDA MEDICAL, INC.: Quarterly Investor Presentation | - | ASX | ||
| 16.07. | SALUDA MEDICAL, INC.: First U.S. Surgical Cases Using CAP24 Paddle Leads | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 37,500 | +2,12 % | Fresenius Medical Care Aktie: Wechsel an der Konzernspitze | Fresenius Medical Care bekommt kurzfristig einen neuen Vorstandschef. Shervin J. Korangy übernimmt mit Wirkung zum 12. Oktober 2026 den Vorsitz des Vorstands. Der Aufsichtsrat hat die Personalie am... ► Artikel lesen | |
| FRESENIUS | 42,355 | +1,84 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,545 | 0,00 % | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,140 | +2,30 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,75 | +0,01 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| GENEDX | 67,33 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| CARL ZEISS MEDITEC | 32,420 | +4,38 % | 200-Tage-Linie hält: Goldman verpasst Zeiss Meditec einen Dämpfer | Goldman Sachs stuft Carl Zeiss Meditec auf "Sell" ab und senkt das Kursziel auf 23 Euro. Zwischenzeitlich verlor das Papier gut sieben Prozent, fing sich dann aber knapp über der 200-Tage-Linie. Die... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 6,630 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| HEARTFLOW | 49,730 | -0,02 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| DRAEGERWERK | 116,60 | +4,67 % | Draegerwerk AG & Co. KGaA: Sechsjähriger FDA-Belastungsfaktor beseitigt; US-Monitoring-Geschäft rückt wieder in den Fokus; KAUFEN | Dräger hat ein sechs Jahre währendes regulatorisches Kapitel im US-Patientenmonitoring endlich abgeschlossen. Nach der FDA-Freigabe (Clearance) von Dräger IACS VG8.1 hat die Behörde den 2020 ausgesprochenen... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,235 | -0,12 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,435 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| BILLIONTOONE | 98,14 | +0,05 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROGYNY | 27,940 | +0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| KESTRA MEDICAL TECHNOLOGIES | 26,980 | 0,00 % | Piper Sandler reiterates Kestra Medical stock rating on patent potential |